Monthly reportRWANDAFDA
Rwanda Food and Drugs Authority — April 2021
What this register recorded from RWANDAFDA in April 2021, what other African authorities published in the same month that bears on it, and what we could not read in RWANDAFDA’s own notices. Every figure here is a count of published regulatory actions. None of it is a finding about Rwanda Food and Drugs Authority.
What RWANDAFDA published
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-RW-2021-40258933 | 14 Apr 2021 | RW | AGOMYCIN Suspension (Erythromycin Estolate Oral Suspension 125mg/5ml), Agog Pharma Limited, India | L96013 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2021-72929136 | 14 Apr 2021 | RW | Telmisartan 40mg Galaxy Pharmaceuticals/India | FF9016 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2021-19673891 | 28 Apr 2021 | RW | Unibrol(Aminosidine)250mg, Universal corporation/Kenya | 5805934 | Recall | Class II | Tier 1 · Regulator-published |
What other authorities published
What we could not read in RWANDAFDA’s notices
- 159 record(s) held from RWANDAFDA in total
- 2 carry no publication date we could read
- 22 name neither a batch nor a stated reason
- 1 name no manufacturer
- 2 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
- 0 have no archived copy of the original notice
Correcting this
Anything on this page that is wrong about Rwanda Food and Drugs Authority can be corrected by Rwanda Food and Drugs Authority, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.